The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients
Open Access
- 30 March 2023
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 12 (4) , 681
Abstract
Beta-lactams (BL) are the first line agents for the antibiotic management of critically ill patients with sepsis or septic shock. BL are hydrophilic antibiotics particularly subject to unpredictable concentrations in the context of critical illness because of pharmacokinetic (PK) and pharmacodynamics (PD) alterations. Thus, during the last decade, the literature focusing on the interest of BL therapeutic drug monitoring (TDM) in the intensive care unit (ICU) setting has been exponential. Moreover, recent guidelines strongly encourage to optimize BL therapy using a PK/PD approach with TDM. Unfortunately, several barriers exist regarding TDM access and interpretation. Consequently, adherence to routine TDM in ICU remains quite low. Lastly, recent clinical studies failed to demonstrate any improvement in mortality with the use of TDM in ICU patients. This review will first aim at explaining the value and complexity of the TDM process when translating it to critically ill patient bedside management, interpretating the results of clinical studies and discussion of the points which need to be addressed before conducting further TDM studies on clinical outcomes. In a second time, this review will focus on the future aspects of TDM integrating toxicodynamics, model informed precision dosing (MIPD) and “at risk” ICU populations that deserve further investigations to demonstrate positive clinical outcomes.Keywords
This publication has 87 references indexed in Scilit:
- Quantitative Impact of Neutrophils on Bacterial Clearance in a Murine Pneumonia ModelAntimicrobial Agents and Chemotherapy, 2011
- Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicityInternal Medicine Journal, 2011
- High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal FunctionAntimicrobial Agents and Chemotherapy, 2010
- Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary PracticesClinical Infectious Diseases, 2009
- Pharmacokinetic issues for antibiotics in the critically ill patientCritical Care Medicine, 2009
- The therapeutic monitoring of antimicrobial agentsBritish Journal of Clinical Pharmacology, 2001
- The therapeutic monitoring of antimicrobial agentsBritish Journal of Clinical Pharmacology, 2001
- EditorialTherapeutic Drug Monitoring, 1997
- Comparison of two Bayesian approaches to dose‐individualization for once‐daily aminoglycoside regimensBritish Journal of Clinical Pharmacology, 1997
- Serum Level Monitoring of Antibacterial DrugsClinical Pharmacokinetics, 1984